PRESIDENT’S CANCER PANEL
THE FUTURE OF CANCER RESEARCH: ACCELERATING SCIENTIFIC
February 1, 2011
Atlanta, Georgia
This meeting was the fourth, and last, in the President’s Cancer Panel’s (PCP, the Panel) 2010-2011 series, The Future of Cancer Research: Accelerating Scientific Innovation. During this meeting, the Panel heard testimony about several novel approaches to research review and funding as well as the value of public-private partnerships in biomedical research.
President’s Cancer Panel
LaSalle D. Leffall, Jr., M.D., F.A.C.S., Chair
Margaret Kripke, Ph.D.
National Cancer Institute (NCI)
Abby Sandler, Ph.D., Executive Secretary, PCP
Gwen Darien, Chair, Director’s Consumer Liaison Group
Speakers
Scott Campbell, Ph.D., Executive Director and CEO, Foundation for the National Institutes of Health E. Melissa Kaime, M.D., Captain, U.S. Navy Medical Corps; Director, Congressionally Directed Medical Research Programs
Donald J. Listwin, Founder and Chairman, Canary Foundation
Chandini E. Portteus, Vice President, Research, Evaluation and Scientific Programs, Medical and Scientific Affairs, Susan G. Komen for the Cure
Howard R. Soule, Ph.D., Executive Vice President and Chief Science Officer, Prostate Cancer Foundation, Senior Fellow, The Milken Institute
William J. Todd, President and CEO, Georgia Cancer Coalition
Yun-Ling Wong, Ph.D., Program Officer, Global Health Discovery, Bill & Melinda Gates Foundation
OPENING REMARKS—LaSALLE D. LEFFALL, JR., M.D., F.A.C.S.
On behalf of the Panel, Dr. Leffall welcomed invited participants and the public to the meeting. He introduced Panel members, provided a brief overview of the history and purpose of the Panel, and described the aims of the current series of meetings. Dr. Leffall also noted that Dr. Michael Goldstein, Co-Chair of the American Society of Clinical Oncology Workforce Advisory Group, was unable to attend the meeting as planned.